Clinical Trial: Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome

Study Status: Completed
Recruit Status: Unknown status
Study Type: Observational




Official Title: Cytokines as Biomarkers and Therapeutic Targets in Paraneoplastic Opsoclonus-Myoclonus Syndrome (OMS)

Brief Summary: The purpose of this study is to determine if cytokines, inflammatory mediators, are increased in spinal fluid and blood, correlate with disease activity, and could serve as biomarkers or therapeutic targets in children with opsoclonus-myoclonus syndrome (OMS), an autoimmune complication of the tumor neuroblastoma.